Top Buy
| Wertpapier | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 29 | 0 | 8 | 0 | 129,45 € | 140,60 € | 8,62 % |
| Biogen Inc. | 47 | 1 | 7 | 1 | 210,30 € | 294,45 € | 40,01 % |
| Vertex Pharmaceuticals Inc. | 46 | 2 | 6 | 0 | 409,80 € | 409,07 € | -0,18 % |
| Insmed Inc. | 18 | 1 | 6 | 1 | 22,60 € | 44,16 € | 95,42 % |
| Eli Lilly Corp. | 51 | 0 | 6 | 0 | 742,00 € | 776,16 € | 4,60 % |
| Intra-Cellular Therapies Inc. | 25 | 0 | 5 | 0 | 62,00 € | 79,55 € | 28,31 % |
| Cytokinetics Inc. | 27 | 1 | 4 | 0 | 55,50 € | 85,64 € | 54,31 % |
| Heron Therapeutics Inc. | 11 | 1 | 4 | 0 | 3,12 € | 4,59 € | 46,90 % |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 4 | 0 | 915,80 € | 959,41 € | 4,76 % |
| MacroGenics Inc. | 12 | 0 | 4 | 0 | 3,91 € | 12,99 € | 232,28 % |
| Zoetis Inc. A | 23 | 1 | 4 | 0 | 159,42 € | 200,06 € | 25,49 % |
| AbbVie Inc. | 22 | 0 | 4 | 0 | 149,98 € | 175,11 € | 16,76 % |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | 10,88 € | 27,80 € | 155,55 % |
| Evolus Inc | 10 | 0 | 4 | 0 | 11,90 € | 20,46 € | 71,95 % |
| United Therapeutics | 19 | 0 | 4 | 0 | 253,50 € | 287,40 € | 13,37 % |
| Amgen Inc. | 25 | 0 | 4 | 0 | 288,50 € | 297,31 € | 3,05 % |
| Exelixis Inc. | 18 | 0 | 3 | 0 | 19,37 € | 26,01 € | 34,26 % |
| XOMA Corp. | 6 | 0 | 3 | 0 | 21,80 € | 68,78 € | 215,50 % |
| Corcept Therapeutics Inc. | 11 | 0 | 3 | 0 | 26,89 € | 35,43 € | 31,76 % |
| Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | 1,38 € | 5,60 € | 305,91 % |
| Gilead Sciences Inc | 11 | 1 | 3 | 0 | 62,12 € | 84,81 € | 36,53 % |
| Novavax Inc. | 5 | 3 | 3 | 2 | 13,80 € | 9,80 € | -29,00 % |
| Twist Bioscience Corp | 7 | 0 | 3 | 0 | 41,17 € | 41,41 € | 0,58 % |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | 27,80 € | 47,53 € | 70,96 % |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | 365,00 € | 421,61 € | 15,51 % |